XXEC Inc’s Pfizer PFE Stock Holding History

XXEC Inc’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-169,942	Closed	-$4.75M	–	23
2024 Q2	$4.75M	Sell	169,942 -2,250	-1%	-$61.9K	3.67%	11
2024 Q1	$4.78M	Buy	172,192 +190	+0.1%	+$5.27K	3.6%	11
2023 Q4	$4.95M	Buy	172,002 +25,535	+17%	+$772K	3.9%	9
2023 Q3	$4.86M	Buy	146,467 +15,757	+12%	+$557K	4.1%	10
2023 Q2	$4.79M	Sell	130,710 -2,600	-2%	-$101K	3.66%	11
2023 Q1	$5.44M	Buy	133,310 +21,041	+19%	+$909K	4.34%	9
2022 Q4	$5.75M	Hold	112,269	–	–	4.61%	8
2022 Q3	$4.91M	Sell	112,269 -13,076	-10%	-$635K	4.23%	11
2022 Q2	$6.57M	Hold	125,345	–	–	5.24%	9
2022 Q1	$6.91M	Hold	125,345	–	–	4.81%	9
2021 Q4	$6.59M	Hold	125,345	–	–	5.62%	7
2021 Q3	$5.39M	Sell	125,345 -81	-0.1%	-$3.59K	4.1%	10
2021 Q2	$4.91M	Sell	125,426 -10	-0%	-$389	3.25%	12
2021 Q1	$4.54M	Buy	125,436 +50,000	+66%	+$1.78M	3.2%	13
2020 Q4	$2.78M	Buy	+75,436	New	+$2.77M	2.18%	18

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

XXEC Inc's PFE Position: Q3 2024 in Review

XXEC Inc sold out of Pfizer (PFE) in Q3 2024, closing a stake of 169,942 shares — an estimated $4.75M sold.

XXEC Inc first reported a position in PFE in Q4 2020 and held it in 15 quarters. The position peaked at $6.91M in Q1 2022. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

XXEC Inc reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
XXEC Inc sold 169,942 Pfizer shares in Q3 2024, an estimated $4.75M.
XXEC Inc first reported a position in Pfizer in Q4 2020 and held it in 15 quarters.
XXEC Inc's Pfizer position peaked at $6.91M in Q1 2022.
2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on XXEC Inc's 13F filing for Q3 2024, filed 5 Nov 2024.